Who is sponsoring NCT06135012?

NCT06135012 is sponsored by University Medical Centre Ljubljana.

What drugs are being tested in NCT06135012?

Interventions in NCT06135012: Cavitron ultrasonic surgical aspirator (CUSA), Scalpel.

What condition does NCT06135012 study?

NCT06135012 studies Pancreatic Fistula.

Is NCT06135012 still recruiting?

NCT06135012 is currently status unknown. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06135012: PANCUT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Pancreatic Transection With CUSA on Postoperative Pancreatic Fistula Incidence (PANCUT)

Status unknown NA Last updated 18 November 2023

What this trial tests

NA trial testing Cavitron ultrasonic surgical aspirator (CUSA) in Pancreatic Fistula in 160 participants. Status unknown.

Timeline

1 July 2023

Primary endpoint
31 July 2025

30 September 2025

Quick facts

Lead sponsor	University Medical Centre Ljubljana
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	160
Start date	1 July 2023
Primary completion	31 July 2025
Estimated completion	30 September 2025
Sites	1 location across Slovenia

Drugs / interventions tested

Cavitron ultrasonic surgical aspirator (CUSA)
Scalpel

Conditions studied

Pancreatic Fistula — all drugs for Pancreatic Fistula →

Sponsor

University Medical Centre Ljubljana

Who can join

18 and older, any sex, with Pancreatic Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To compare the outcomes after elective pancreatic resections using cavitron ultrasonic surgical aspirator (CUSA) and selective closure of small blood vessels and branch pancreatic ducts versus surgical scalpel or stapler for the transection of pancreatic tissue. Study design: A randomized controlled, single centre trial. Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication. Intervention: Transection of pancreatic tissue with CUSA. Control: Standard transection of pancreatic tissue with surgical scalpel (in PD) or stapler (in DP)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Influence of pancreas transection with cavitron ultrasonic surgical aspirator (CUSA) on incidence of postoperative pancreatic fistula after pancreatoduodenectomy (PANCUT): study protocol for a randomised controlled trial.
Hadžialjević B, Zavrtanik Čarni H, Petrič M, Đokić M, et al · · 2025 · PMID 40462161 · DOI 10.1186/s13063-025-08898-4

Verify or expand the search:

Other recruiting trials for Pancreatic Fistula

Currently open trials in the same condition.

NCT07144917 — Immunoparalysis After Pancreaticoduodenectomy · recruiting
NCT07139236 — Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD · recruiting
NCT07022015 — Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy · NA · recruiting
NCT07009119 — Laparoscopic Pancreaticoduodenectomy · NA · recruiting
NCT06756074 — Reinforced Pancreaticojejunostomy With or Without glubran2 · Phase 2 · recruiting

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06135012 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06135012.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing